proroxan has been researched along with Liver Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gurkalo, VK; Krylov, SS; Pliss, GB; Zabezhinskiĭ, MA | 1 |
1 other study(ies) available for proroxan and Liver Neoplasms
| Article | Year |
|---|---|
[Adrenergic component in the hepatotropic, carcinogenic effect of diethylnitrosamine].
Topics: Adrenergic alpha-Antagonists; Animals; Antineoplastic Agents; Carcinogens; Diethylnitrosamine; Dioxanes; Dioxins; Liver Neoplasms; Male; Neoplasms, Experimental; Nitrosamines; Norepinephrine; Pyrrolidines; Rats | 1977 |